Literature DB >> 20931400

The guideline of the design and validation of MiRNA mimics.

Zhiguo Wang1.   

Abstract

The miRNA mimic technology (miR-Mimic) is an innovative approach for gene silencing. This approach is to generate nonnatural double-stranded miRNA-like RNA fragments. Such an RNA fragment is designed to have its 5'-end bearing a partially complementary motif to the selected sequence in the 3'UTR unique to the target gene. Once introduced into cells, this RNA fragment, mimicking an endogenous miRNA, can bind specifically to its target gene and produce posttranscriptional repression, more specifically translational inhibition, of the gene. Unlike endogenous miRNAs, miR-Mimics act in a gene-specific fashion. The miR-Mimic approach belongs to the "miRNA-targeting" and "miRNA-gain-of-function" strategy and is primarily used as an exogenous tool to study gene function by targeting mRNA through miRNA-like actions in mammalian cells. The technology was developed by my research group (Department of Medicine, Montreal Heart Institute, University of Montreal) in 2007 (Xiao, et al. J Cell Physiol 212:285-292, 2007; Xiao et al. Nat Cell Biol, in review).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20931400     DOI: 10.1007/978-1-60761-863-8_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  55 in total

Review 1.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

Review 2.  Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Authors:  Daniela Schmitter; Gadi Cotter; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 3.  microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.

Authors:  Christian Schulte; Tanja Zeller
Journal:  Cardiovasc Diagn Ther       Date:  2015-02

Review 4.  Anti-miRNA oligonucleotides: A comprehensive guide for design.

Authors:  Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo
Journal:  RNA Biol       Date:  2018-03-23       Impact factor: 4.652

5.  miR-29a up-regulation in AR42J cells contributes to apoptosis via targeting TNFRSF1A gene.

Authors:  Qiang Fu; Tao Qin; Lin Chen; Chuan-Jiang Liu; Xu Zhang; Yu-Zhu Wang; Ming-Xing Hu; Hao-Yuan Chu; Hong-Wei Zhang
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 6.  Progress in microRNA delivery.

Authors:  Yu Zhang; Zaijie Wang; Richard A Gemeinhart
Journal:  J Control Release       Date:  2013-09-25       Impact factor: 9.776

7.  Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction.

Authors:  Emily K Glover; Nina Jordan; Neil S Sheerin; Simi Ali
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 8.  MicroRNAs and drug resistance in prostate cancers.

Authors:  Feng Li; Ram I Mahato
Journal:  Mol Pharm       Date:  2014-04-29       Impact factor: 4.939

9.  The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation.

Authors:  Sebastian Clauss; Moritz F Sinner; Stefan Kääb; Reza Wakili
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01

10.  Expanding the Differentiation Potential of Already-Established Pluripotent Stem Cells.

Authors:  José González-Martínez; Marcos Malumbres
Journal:  Methods Mol Biol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.